These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39015682)

  • 21. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience.
    Pieri M; Contri R; Winterton D; Montorfano M; Colombo A; Zangrillo A; De Bonis M; Pappalardo F
    BMC Cardiovasc Disord; 2015 Oct; 15():126. PubMed ID: 26466899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical circulatory support with the Impella 5.0 and the Impella Left Direct pumps for postcardiotomy cardiogenic shock at La Pitié-Salpêtrière Hospital.
    David CH; Quessard A; Mastroianni C; Hekimian G; Amour J; Leprince P; Lebreton G
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):183-188. PubMed ID: 31270535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of hundred large Impella implantations in cardiogenic shock patients based on individual clinical scenarios.
    Sugimura Y; Bauer S; Immohr MB; Mehdiani A; Rellecke P; Tudorache I; Horn P; Westenfeld R; Boeken U; Aubin H; Lichtenberg A; Akhyari P
    Artif Organs; 2023 Dec; 47(12):1874-1884. PubMed ID: 37724611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO.
    Karami M; den Uil CA; Ouweneel DM; Scholte NT; Engström AE; Akin S; Lagrand WK; Vlaar AP; Jewbali LS; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):164-172. PubMed ID: 31353918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.
    Napp LC; Westenfeld R; Møller JE; Pappalardo F; Ibrahim K; Bonello L; Wilkins C; Pershad A; Mannino SF; Schreiber TL; Hall PA; Medjamia AM; Haurand JM; Sieweke JT; Schäfer A; Grines CL; Burkhoff D; Moses JW; Ohman EM; O'Neill WW; Kapur NK; Bauersachs J
    Cardiovasc Revasc Med; 2022 Jul; 40():113-119. PubMed ID: 34916157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock.
    Bhatia K; Jain V; Hendrickson MJ; Aggarwal D; Aguilar-Gallardo JS; Lopez PD; Narasimhan B; Wu L; Arora S; Joshi A; Tomey MI; Mahmood K; Qamar A; Birati EY; Fox A
    Am J Cardiol; 2022 Oct; 181():94-101. PubMed ID: 35999070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
    J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle.
    Josiassen J; Helgestad OKL; Udesen NLJ; Banke A; Frederiksen PH; Hyldebrandt JA; Schmidt H; Jensen LO; Hassager C; Ravn HB; Møller JE
    Intensive Care Med Exp; 2020 Aug; 8(1):41. PubMed ID: 32785808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.
    Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP
    Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care.
    Scherer C; Lüsebrink E; Kupka D; Stocker TJ; Stark K; Stremmel C; Orban M; Petzold T; Germayer A; Mauthe K; Kääb S; Mehilli J; Braun D; Theiss H; Brunner S; Hausleiter J; Massberg S; Orban M
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications and Outcomes in 39,864 Patients Receiving Standard Care Plus Mechanical Circulatory Support or Standard Care Alone for Infarct-Associated Cardiogenic Shock.
    Padberg JS; Feld J; Padberg L; Köppe J; Makowski L; Gerß J; Dröge P; Ruhnke T; Günster C; Lange SA; Reinecke H
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience.
    Nersesian G; Hennig F; Müller M; Mulzer J; Tsyganenko D; Starck C; Gromann T; Falk V; Potapov E; Schoenrath F
    Ann Cardiothorac Surg; 2019 Jan; 8(1):76-83. PubMed ID: 30854315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany.
    Bernhardt AM; Potapov E; Schibilsky D; Ruhparwar A; Tschöpe C; Spillmann F; Benk C; Schmack B; Schmitto JD; Napp LC; Mayer-Wingert N; Doll N; Reichenspurner H; Schulte-Eistrup S
    J Heart Lung Transplant; 2021 Aug; 40(8):850-855. PubMed ID: 34030970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impella 5.0 supported oncological surgery as bridge to LVAD.
    Montisci A; Micheletto G; Sibilio S; Donatelli F; Tespili M; Banfi C; Casilli F; Cosseta D; Miceli A; Cirri S; Pappalardo F
    ESC Heart Fail; 2021 Feb; 8(1):167-170. PubMed ID: 33161652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience.
    Balder JW; Szymanski MK; van Laake LW; van der Harst P; Meuwese CL; Ramjankhan FZ; van der Meer MG; Hermens JAJM; Voskuil M; de Waal EEC; Donker DW; Oerlemans MIFJ; Kraaijeveld AO
    Neth Heart J; 2024 Jun; 32(6):245-253. PubMed ID: 38713449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impella 5.0 as a Second-Line Mechanical Circulatory Support Strategy After Extracorporeal Life Support.
    Schibilsky D; Kruger T; Lausberg HF; Eisenlohr C; Haller C; Nemeth A; Schibilsky B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2016 Sep; 40(9):909-16. PubMed ID: 27645397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.